BOSTON ( TheStreet) -- Biotechnology companies are rife with opportunity. And risk. The following biotech stocks may offer superlative rewards, according to TheStreet's quantitative equity model, which is more conservative than many research tools. Plus, sell-side analysts are overwhelmingly bullish on their prospects.
2. Gilead Sciences ( GILD) develops therapeutics for life-threatening diseases. Gilead is a major biotech player, with a market value of $43 billion.
1. Alexion Pharmaceuticals ( ALXN) makes drugs for patients in severe disease states, including those with hematologic, cardiovascular and autoimmune disorders.